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Background: Whey protein is known to reduce postprandial glycaemia in people with
type 2 diabetes mellitus. Lupin as a vegetable source of protein could be considered
as an alternative, as the percentage of vegetarian and vegan consumers is raising.
The present study compares the acute glycemic effects of whey and lupin in healthy
volunteers following a carbohydrate-rich reference meal.
Methods In cross-over design, three standardized meals (reference meal; reference
meal + whey; reference meal + lupin) were provided to 12 healthy male and female
volunteers, aged between 23 and 33, in a balanced, randomized order. Volunteers’ blood
glucose and insulin concentrations were analyzed at baseline and at seven time points
following the ingestion of the meals.
Results: The supplementation of whey or lupin significantly blunted the postprandial
increase in blood glucose concentrations compared to the reference meal (p < 0.001).
In the overall statistical analysis, this effect was comparable for whey and lupin [1 AUC
whey-lupin = 8%, 0–60 min area under the curve (0–60 min AUC), p = 0.937], with a
blunting effect of −46% by whey (p = 0.005, 0–60 min AUC) and of −54% by lupin (p <
0.001, 0–60 min AUC). When comparing whey and lupin data only, the insulin increase
was found to be more pronounced for whey protein than for lupin supplementation (1
AUC whey-lupin = 39%, 0–60 min AUC, p = 0.022). However, when comparing the
insulin response of each supplementation to the one of the reference meal, no differences
could be detected (whey p = 0.259, 0–60 min AUC; lupin p = 0.275, 0–60 min AUC).
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Conclusions: Results suggest that lupin and whey can both lower the increase of
postprandial blood glucose concentrations to a comparable extent, implying the usability
of lupin to reduce postprandial glycaemia. However, the insulin response following the
supplementations to a carbohydrate-rich meal seems to differ for these two protein
sources.
Keywords: Lupinus albus, lupin, whey, blood glucose, serum insulin, dietary protein, postprandial responses,
glycemic control
Clinical trial registry number and website: The trial was retrospectively registered on ClinicalTrials.gov under
number NCT02413671.
INTRODUCTION
The development of insulin resistance and high blood glucose
concentrations in people with type 2 diabetes mellitus (T2DM)
are often linked to obesity, physical inactivity or poor
diet (International Diabetes Federation, 2015). Notably, these
manifestations can be prevented, or even reversed by physical
exercise and dietary interventions (International Diabetes
Federation, 2015). Such dietary interventions may include
increasing the consumption of food items with a low glycemic
index (GI) (Brand-Miller et al., 2002) or a low glycemic load
(GL) (Dong et al., 2011), i.e., numbers which indicate a food’s
potential of increasing postprandial blood glucose concentrations
after consumption. Furthermore, food can be supplemented with
certain proteins (Gannon et al., 1988, 2003; Nilsson et al., 2004;
Frid et al., 2005; Pal et al., 2010; Bertoglio et al., 2011; Dove et al.,
2011; Baldeón et al., 2012; Fornasini et al., 2012; Silva Ton et al.,
2014).
Whey protein has come into focus over the last decade for its
benefits in T2DM. The protein is a mixture of globular proteins
isolated from whey, which is a by-product of cheese production
and known to stimulate insulin release and to lower postprandial
glycemia in type 2 diabetic patients (Frid et al., 2005) as well as
in healthy participants (Nilsson et al., 2004). Nevertheless, as an
animal protein with a high content of sulfur-containing amino
acids, it might lead to so called low-grade metabolic acidosis
if taken in high amounts (Frassetto et al., 2001). Changing the
body’s acid-base homeostasis toward the acidic side might entail
a number of undesirable effects, such as an increased bone
resorption (Frings-Meuthen et al., 2008), or the stimulation of
muscle protein degradation, either by affecting the regulation
of branched-chain amino acid metabolism (May et al., 1987)
or by activating the adenosine triphosphate-dependent pathway
(Mitch et al., 1994). Moreover, evidence relates the risk of hip
fracture to high animal protein intake (Frassetto et al., 2000).
Taken together, this forms a rationale to seek for alternative ways
of protein supplementation, most intuitively by protein from
vegetable sources.
The question therefore arises whether such vegetable proteins
have similar effects upon glucose metabolism as whey protein.
Abbreviations: BL, Baseline; BW, Body weight; CH, Carbohydrate; F, Fat;
GI, Glycemic index; GIP, Glucose-dependent insulinotropic polypeptide; GL,
Glycemic load; GLM, General linear model; GLP-1, Glucagon-like pepide 1;
GLUT4, Glucose transporter 4; H2O, Dihydrogen monoxide; kJ, Kilo joule; LME,
Linear mixed effects; PCOS, Polycystic ovary syndrome; P, Protein; SD, Standard
deviation; SEM, Standard error of the mean; T2DM, Type 2 diabetes mellitus.
Because of its lower content of sulfur containing amino acids
such as cysteine and methionine, we have become especially
interested in lupin seeds. The lupin flower belongs to the legume
family (Fabaceae) and produces seeds that contain a high amount
of protein (up to 40%). Very interestingly, it has been shown to
reduce postprandial hyperglycemia (Bertoglio et al., 2011; Dove
et al., 2011; Baldeón et al., 2012). Additionally, it could serve as
vegan alternative to whey protein, as the percentage of vegetarian
and vegan consumers is increasing rapidly over the last years.
Nevertheless, there is no direct comparison yet between whey and
lupin’s effects upon glycemic control.
Hence, the present study was performed in order to compare
the effect of whey and lupin supplementation to a carbohydrate-
rich reference meal on postprandial blood glucose and insulin
responses in healthy human participants. We hypothesized that
lupin would lower postprandial glycemia to a comparable extent
as whey.
PARTICIPANTS AND METHODS
Participants and Study Design
Five healthy male (height: 1.82 ± 0.08 m, body weight (BW):
81.8 ± 13.16 kg, body mass index (BMI): 24.72 ± 2.3 kg/m2,
age: 28 ± 3.67 y) and seven female volunteers (height: 1.69 ±
0.08 m, BW: 69.69 ± 5.52 kg, BMI: 20.92 ± 1.63 kg/m2, age:
26.86 ± 3.44y) participated in this cross-over designed study,
which consisted of three test visits (Table 1). All participants
were recruited in-house by word-of-mouth (Supplementary
Material, Image 1). An a priori sample size estimation was
performed with GPower (version 3.1.9.2, university of Kiel,
Germany). F-test based MANOVA with an effect size of 0.57, a
p-value of 0.05 and a power of 0.80 yielded a required sample
size.
A medical screening was performed before including subjects.
Inclusion criteria included fasting plasma glucose levels within
the normal range (70–99 mg/dl) and HbA1c within the range
of 4–6 %. Participants were single-blinded, and the different
test meals were provided in balanced randomized order, with
a minimum of 24 h between successive test days. The study
lead assigned a number to each of the three test meals
and all possible permutations were equally distributed among
participants, resulting in two randomly assigned participants
receiving test meals in the same sequential order. For the
duration of the study, volunteers were asked refrain from high
fatty food items (e.g., pizza, fries, etc.), and alcohol. After a
fasting blood draw for baseline data (BL1), participants received
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TABLE 1 | Participants characteristics (n=12, individual values).
Subject Gender Height (m) BW (kg) BMI (kg/m2) Age (y)
A f 1.57 52.50 21.30 27
B f 1.71 66.00 22.57 31
C f 1.84 67.30 19.88 32
D m 1.74 75.00 24.77 25
E f 1.69 56.00 19.61 25
G f 1.70 57.00 19.72 23
H f 1.70 57.00 19.72 24
K m 1.72 70.00 23.66 24
L f 1.62 62.00 23.62 26
M m 1.87 88.00 25.17 30
O m 1.85 74.00 21.74 28
P m 1.90 102.00 28.25 33
a standardized breakfast, consisting of rye bread, butter, jam,
cheese, ham and either coffee or tea. This was done in an
effort to standardize the dietary conditions prior to the actual
test meal. The items chosen by participants for breakfast at
the first visit were noted, and the same items were presented
to each subject for the subsequent two breakfasts. Four hours
after consumption of the breakfast, a second blood sample was
obtained (BL2), followed by the ingestion of a standardized
test meal at lunch time. The latter was tailored to body weight
(Table 2) and rich in carbohydrates. It was either provided
alone (here called reference meal), or supplemented with either
whey (henceforth called whey meal) or with lupin (henceforth
called lupin meal) (Figure 1). As in previous studies, a 12-
min period had been chosen for meal consumption since
glucose and insulin responses are expected to start shortly
after meal consumption (Frid et al., 2005). The participants
ate steadily over a 12-min time period and finished the
complete meals under supervision. Once the meal was finished,
further blood samples were drawn at +10, +20, +30, +40,
+60, +120, and +180 min through an in-dwelling venous
catheter.
The study protocol was in accordance with the Declaration
of Helsinki, and had been approved by the ethics committee
of the Aerztekammer Nordrhein (Ethikkommission der
Aerztekammer Nordrhein, Duesseldorf, Germany) before
study commencement. The study is registered on http://www.
clinicaltrials.gov under trial number: NCT02413671. Written
informed consent was obtained from all participants.
Lunch Meals
The reference meal consisted of spaghetti with meat sauce
(Apetito, Rheine, Germany) and was supplemented with either
lupin or whey or served without supplementation. The amount
of supplement was dependent on participants’ body weight
(Table 2).
Protein Supplementation
Whey protein isolate was obtained as Diaprotein from Dr.
Steudle (Linden, Germany) and lupin as sweet lupin flour from
BIOTICANA GmbH (Rendswühren, Germany). On the basis of
the actual literature, whey protein was supplemented as 0.42 g
whey protein per kg body weight. To add an equivalent amount
of protein from lupin flour, the reference meal was supplemented
with 0.94 g of lupin flour per kg body weight. The respective
supplementations were added to and mixed with the sauce and
noodles immediately before the meals were served. Nutritional
breakdown of sweet lupin flour and whey protein isolate is
provided in Table 3.
The concentrations of methionine and cysteine for both
supplementations were analyzed by a local laboratory (Eurofins
Laborservice GmbH, Cologne, Germany) using ion-exchange
chromatography.
Blood Sample Analysis
Blood samples were centrifuged (3000 rpm, 4◦C, 10 min)
after coagulation. Plasma glucose concentrations were analyzed
with an automated analyzer (INTEGRA 400+, Roche, Basel,
Switzerland). The remaining plasma was distributed in small
tubes and immediately frozen at −80◦C until analysis for insulin
concentrations.
Insulin concentrations were analyzed with a commercially
available ELISA (MERCODIA, Uppsala, Sweden) in the in-house
laboratory of the Institute of Aerospace Medicine, Germany with
an intra-assay variation of 1.2%.
Data Processing and Statistical Analysis
The areas under the curve (AUCs) for the glucose and insulin
tracings were calculated for each subject and each meal using
GraphPad Prism (version 5.01; GraphPad Software Inc, San
Diego, USA). All AUCs below baseline were excluded from the
calculations. The AUCs were expressed as means ±SDs. Time
point analysis was performed to evaluate differences between
whey and lupin.
All statistical analyses were performed with IBM SPSS (V.20,
Chicago, Illinois). Group mean values with their SEM were
calculated for each condition of interest.
For AUC values, a general linear model (GLM) was used
to assess significance. For time point analysis a linear mixed-
effects (LME) model was used with substance, time and their
interaction as fixed effects and participants as a random effect.
The respective model means and standard errors are presented
in the graphs. An alpha level of 0.05 was set for all tests for
significance. Moreover, normal distribution of the raw data was
verified by the Kolmogorov-Smirnov-test. The residuals were
tested to be normally distributed to confirm the appropriateness
of the statistical modeling.
RESULTS
Sulfur Amino Acid Content of Whey and
Lupin
Whey protein was found to contain an amount of 2.28 g of
methionine and of 2.41 g of cysteine per 100 g. For lupin the
content of methionine amounted to 0.13 g, and for cysteine to
0.61 g per 100 g.
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TABLE 2 | Nutritional values for the three meals (reference meal, whey meal, lupin meal) per kg body weight.
kJ P (g) F (g) SFA (g) CH (g) S (g) Na (mg) Ca (mg) H2O (g)
Reference Meal 29.1 0.32 0.21 0.06 0.89 0.12 22.6 0.99 4.45
Lupin Meal 38.9 0.69 0.30 0.07 0.90 0.13 22.6 0.99 4.45
Whey Meal 35.9 0.69 0.21 0.06 0.90 0.13 23.9 2.65 4.45
The table includes calories (kJ), protein (P), fat (F), saturated fatty acids (SFA), carbohydrates (CH), sugar (S), sodium (Na), calcium (Ca) and Water (H2O).
FIGURE 1 | Exemplary testing protocol for one subject.
TABLE 3 | Nutritional breakdown of sweet lupin flour and whey protein
isolate per 100 g.
kJ P (g) F (g) SFA (g) CH (g) S (g)
Lupin Protein 1,047 39.3 9.8 1.5 1.2 1.2
Whey Protein 1,549 90.0 1.2 1.0 2.5 2.5
The table includes calories (kJ), protein (P), fat (F), saturated fatty acids (SFA),
carbohydrates (CH) and sugar (S).
Postprandial Response
All meals led to a significant transient increase in postprandial
blood glucose (p < 0.001) and serum insulin concentrations
(p = 0.001). The fasting blood glucose and serum insulin
concentrations (BL1) as well as the baselines measured directly
before the ingestion of the meal (BL2) were comparable between
the three test days (blood glucose: all: p> 0.69; serum insulin: all:
p> 0.25).
AUC Analysis
Postprandial blood glucose concentrations (as AUC) are shown
in Table 4. Statistically, no differences in glucose concentration
were observed between the supplementation with whey and
lupin (0–60 min AUC: p = 0.937; 0–180 min AUC: p = 1.000).
Compared to the reference meal, the blood glucose response
within the first 60 min after meal consumption was reduced
by 45.97 ± 10% (p = 0.005) when supplemented with whey
protein. Over the interval of 0–180 min, blood glucose AUC was
reduced by −34.54 ± 10% for the whey meal (p = 0.040). For
the supplementation with lupin the 0–60min blood glucose AUC
was reduced by−53.49± 9% (p< 0.001) for the 0–60 min AUC,
and by and −34.64 ± 11% over the 0–180 min interval (p =
0.030) when compared to the reference meal.
The postprandial serum insulin concentrations (as AUC) are
also shown in Table 4.
The insulin response in the 0–60 min AUC was higher
following the consumption of the whey meal than after the lupin
meal (p = 0.022). However, there was no difference found at
180 min after meal ingestion (p = 1.000).When compared with
the reference meal, neither had whey protein supplementation
any detectable effect (0–60 min AUC: +23.20 ± 14%, p =
0.259; 0–180 min AUC: 14.54 ± 14%, p = 0.656), nor had the
supplementation with lupin (0-60 min AUC:−16.42± 13%, p=
0.275; 0–180 min AUC: 4.78± 15%, p= 1.000).
Time Point Analysis
Postprandial blood glucose concentrations are shown in
Figure 2. Notably, fasting blood glucose concentrations were
within the normal range (reference: 86.88 mg/dl; whey: 87.79
mg/dl; 89.39 mg/dl). A significant difference between whey and
lupin was observed only at time point +20 min, with lower
blood glucose concentrations for the lupin meal as compared
to the whey meal (p = 0.040). Postprandial blood glucose
concentrations were lower at 10 min (p = 0.013), at 20 min (p
= 0.005), at 30 min (p < 0.001), at 40 min (p < 0.001), and at 60
min (p= 0.028) after consumption of the wheymeal as compared
to the reference meal, but no difference were observed at +120
min and +180 min p = 1.000 and p = 0.356, respectively). For
the supplementation with lupin, with respect to the reference
meal, significantly lower postprandial glucose concentrations
were observed at 10 min (p< 0.001), 20 min (p< 0.001), 30 min
(p < 0.001) and 40 min (p = 0.003), whilst no differences were
observed for the time points +60 min, +120 min and +180 min
(p= 0.647, p= 1.000, and p= 0.163, respectively).
Postprandial serum insulin concentrations are shown in
Figure 3. All fasting serum insulin concentrations were within
the normal range (reference: 4.27 mU/l; whey: 4.39 mU/l;
lupin: 5.69 mU/l). Comparing the insulin response following
the whey and the lupin meal, supplementation with lupin
led to significantly lower serum insulin concentrations than
supplementation with whey protein at time points +10 min
(p = 0.037), +20 min (p < 0.001) and +30 min (p = 0.014).
From time point +40 min onwards, no significant difference
were observed (all p > 0.6). Supplementation with whey protein
led to higher insulin responses at 20 and at 30 min after
consumption when compared with the reference meal (p= 0.004
and p = 0.032, respectively. No such differences were observed
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TABLE 4 | Postprandial area under the curve (AUCs, ± SEM) for blood glucose and serum insulin after the reference, whey and lupin meal in healthy
human participants.
Reference Whey 1 (Ref-Whey) [%] Lupin 1 (Ref-Lupin) [%] 1 (Whey-Lupin) [%]
GLUCOSE AUC [MG·MIN/DL]
0–60 min 1984 ± 174 1072 ± 135 −46 ± 10** 923 ± 128 −54 ± 9*** 8 ± 10
0–180 min 3809 ± 474 2493 ± 342 −35 ± 10* 2489 ± 391 −35 ± 11* 0 ± 12
INSULIN AUC [MU·MIN/L]
0–60 min 1583 ± 202 1951 ± 257 23 ± 14 1323 ± 186 −16 ± 13 39 ± 15*
0–180 min 3216 ± 582 3684 ± 539 15 ± 14 3373 ± 643 5 ± 15 10 ± 15
***p < 0.001; **p = 0.001–0.01; *p > 0.01–0.05.
FIGURE 2 | Mean (± SEM) of blood glucose concentrations in mg/dl
over 180 min following the three different meals:  representing the
reference meal, N representing the meal supplemented with whey, •
representing the meal supplemented with lupin, * representing
differences between the lupin and the reference meal, + representing
differences between the whey and the reference meal and #
representing differences between the lupin and the whey meal.
***/+++/###p < 0.001; **/++/##p = 0.001–0.01; */+/#p > 0.01–0.05.
at time points +10 min, and at +40 min to +180 min (all p >
0.90). Serum insulin concentrations differed between after lupin
supplementation and after the reference meal at time point +10
min (p = 0.047)only, but not at any other time point (all p >
0.21).
DISCUSSION
In the present study, we have compared the effects of
whey and lupin supplementation on postprandial blood
glucose concentrations and the serum insulin response in
healthy human participants in comparison to a reference,
carbohydrate-rich, meal. Within the first 60 min, whey and
lupin supplementation led to a comparable blunting of
postprandial glycemia (whey: −46%; lupin: −54%, 0–60 min
AUC, respectively). Whilst this may not be surprising, it is
astounding that the insulin responses were quite different
FIGURE 3 | Mean (± SEM) of serum insulin concentrations in mU/l over
180 min following the three different meals:  representing the
reference meal, N representing the meal supplemented with whey, •
representing the meal supplemented with lupin, * representing
differences between the lupin and the reference meal, + representing
differences between the whey and the reference meal and #
representing differences between the lupin and the whey meal.
***/+++/###p < 0.001; **/++/##p = 0.001–0.01; */+/#p > 0.01–0.05.
after the two meals. In addition, we find it remarkable that,
despite the increased caloric load in the supplemented meals,
the two supplementations did entail blunted hyperglycemic
responses.
The observed glycemia-lowering effect of whey protein
is consistent with previous studies. Pal et Ellis, for instance
observed a lower incremental AUC for blood glucose
concentrations when comparing whey to a turkey or egg
albumin liquid test meal in healthy men (Pal and Ellis, 2011).
A blunted hyperglycemic response by approximately 20%
has also been shown in T2DM patients (Frid et al., 2005),
and by more than 50% in healthy volunteers (Nilsson et al.,
2004). By contrast, the insulin response in our study was
seemingly higher at some postprandial time points, albeit was
not when expressed as AUC. This finding is partly at odds with
previous studies that have demonstrated a significant increase
in the incremental insulin also in AUC after whey protein
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supplementation (Nilsson et al., 2004; Frid et al., 2005; Pal and
Ellis, 2011).
Despite the glycemia-lowering potential of lupin, there are
only a few human studies to date available. Dove et al. observed
a glucose-lowering effect in diabetic adults when supplementing
a glucose containing beverage with lupin kernel flour (Dove
et al., 2011). Another study investigating the effect of lupin
kernel flour in healthy participants found a reduced incremental
glucose AUC after consuming lupin kernel flour-enriched bread
compared with consuming white bread (Lee et al., 2006). While
the study by Dove et al. led to significant higher insulin and C-
peptide concentrations, the study of Lee et al. induced a reduced
incremental insulin AUC, which is more consistent with the
present study.
Despite the similarities in the postprandial glucose lowering
effect of the supplements used in the present study, they
differ in the evoked insulin response. In line with previous
studies, whey protein mostly leads to an increase in insulin
concentrations, either observed as AUC or, as in our study,
only at certain time points. Thus, while lupin can lead to an
increase and also to a decrease in serum insulin concentrations,
there seems to be a consistent effect in lowering postprandial
glycemia. For both, whey and lupin, the exact mechanism
lowering postprandial glycemia is not yet known. Regarding
whey protein, several studies have shown that certain amino
acids, especially branch-chained amino acids, seem to act as
insulin secretagogues (Loon et al., 2000; Nilsson et al., 2007).
Furthermore, we have to take into account the higher amount
of calcium provided with the whey meal. As natural trigger
of the pancreatic islets of Langerhans it might lead to an
increased insulin secretion (Mears, 2004). Hall et al. found a
significant increase in plasma amino acids after whey preload
with highly significant increases in serum branched-chain amino
acids. In addition, they observed a significant increase in incretin
hormone concentrations: Glucagon-like peptide (GLP-1) and
glucose-dependent insulinotropic polypeptide (GIP) were both
significantly increased after whey preload (Hall et al., 2003), an
observation that is consistent with other studies (Frid et al., 2005;
Ma et al., 2009).
The additional stimulation of insulin secretion by the whey
induced rise of certain amino acids and incretin hormones
may accelerate glucose uptake into muscle cells through the
insulin-dependent pathway of glucose transporter 4 (GLUT4).
A supplementation with whey protein might indirectly intensify
the activation of that pathway leading to a faster decrease
in postprandial glycemia. However, in our study, we did not
observe such pronounced increases in insulin concentrations
that were reported in other studies, while postprandial glycemia
was reduced to a similar extent (Nilsson et al., 2004; Frid et al.,
2005; Pal and Ellis, 2011). This might be due to the fact that the
aforementioned studies used more insulin response stimulating
referencemeals, such as pure glucose beverages or high-GImeals.
In addition, some studies worked with T2DM patients in whom
the effects might be different to the ones in healthy men. In
addition, the quality and quantity of the given supplementation
might differ between the studies, leading to variable pronounced
effects.
The mechanism underlying the reduced increase in
postprandial blood glucose concentrations may to be different
between whey and lupin. Two different lupin components
seem to be mainly responsible for the hypoglycemic effect.
Baldeón et al. tested purified alkaloids of lupinus mutabilis
for their hypoglycemic impact in people with type 2 diabetes.
The authors showed a significant reduced postprandial
increase in blood glucose concentrations over 90 min.
Serum insulin concentrations were not affected (Baldeón
et al., 2012). In contrast, Bertoglio et al. and Lovati et al.
tested the glucose lowering effect of γ-conglutin, a small
glycoprotein in lupins (Duranti et al., 2008; Bertoglio et al.,
2011; Rosa Lovati et al., 2012). In 2011, Bertoglio et al. tested
purified γ-conglutin in several dosages in rats and healthy
humans and the authors observed a dose-dependent reduced
increase in postprandial glycemia (Bertoglio et al., 2011).
Administration of γ-conglutin for 21 days to hyperglycemic
rats attenuated the rise in plasma glucose and serum insulin
concentrations significantly when compared to glucose-
fed rats (Rosa Lovati et al., 2012). The same study also
showed that γ-conglutin supports the activity of insulin and
metformin in glucose consumption of HepG2 cells (Rosa Lovati
et al., 2012), whereas other studies have demonstrated the
internalization and phosphorylation of γ-conglutin (Capraro
et al., 2010), the insulin-binding (Magni et al., 2004) and
the insulin-mimetic action (Terruzzi et al., 2011) of the
glycoprotein in vitro. Collectively, these studies suggest the
involvement of γ-conglutin in the hypoglycemic effect of
lupin.
However, the exact mechanism still remains unclear and
in vivo studies have to be performed to investigate the role
of γ-conglutin in decreasing postprandial glycemia without a
corresponding insulin response. Thus, it is currently unknown
how γ-conglutin is processed upon administration, or even
whether the protein reaches the insulin receptor fully intact.
Furthermore, it is not clear whether other lupin components,
such as e.g. alkaloids or fiber intensify the effect of γ-conglutin.
In addition, whether an insulin-mimetic action is the only
mechanism leading to a reduced postprandial glycemia or
whether other reactions, such as a delayed resorption, or an
inhibition of hepatic gluconeogenesis also play a role, will have
to be investigated. Because of these unknowns, we decided to
perform the present study with integral lupin flour containing all
lupin components. However, using integral lupin flour results in a
higher consumption of fat, which was shown to influence insulin
secretion. Whether this was the triggering factor for the lower
insulin secretion remains unclear, since it was shown that high-fat
diets could lead to both, insulin resistance and impaired insulin
secretion (Fu et al., 2009; Salimi et al., 2016). Further studies
are necessary to identify the components which are responsible
for the glucose lowering effect and whether these components
are as effective as whey protein. Additionally, further studies
should evaluate, whether the lower glucose response occurs due
to the protein supplementation itself or whether the type of
protein is the triggering this effect. Future studies should also
investigate the absorption and localization of glucose upon lupin
administration.
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LIMITATIONS
As a first approach to the short-term effects of a lupin and whey
supplementation on the postprandial blood glucose response,
this study and budgetary restrictions led to some compromises.
For, example, two participants had BMIs in the overweight
range. However, their HbA1c levels were within normal range,
and we therefore trust that inclusion of their data into the
statistical analysis is justifiable. Additionally, BMI values varied
substantially between male and female participants, which may
raise questions regarding to homogeneity of subjects. On the
other hand, variation in these anthropometric values may speak
in the favor of generalizability of the study. However, future
studies should be performed with two separate gender groups
or with a smaller variation in BMI values within the participant
cohort in order to reduce sources of variation, and in order to
thus better establish the physiological mechanisms involved in
the glucose and insulin responses. Additionally, meals could be
supplemented with other nutrients, such as fat or calcium in
order to balance the meals and to enable a better comparability
of the meals. The same applies for a supplementation of the
reference meal with another protein.
CONCLUSIONS
In conclusion, the present study has shown that supplementation
with lupin can reduce postprandial glycemia in healthy human
participants, and perhaps even more than supplementation with
whey protein. Even though the exact mechanism of action still
remains unclear and we only conducted as short- term effect
study with healthy participants, these results suggest that lupin
can potentially serve as a vegetable alternative for whey protein
in the control and prevention of glycemia.
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